Evidence map›Paper›PMID 32565914›Full record

ReviewTherapeutic advances in neurological disorders2020

Neurological manifestations and implications of COVID-19 pandemic.

Georgios Tsivgoulis, Lina Palaiodimou, Aristeidis H Katsanos, Valeria Caso, Martin Köhrmann, Carlos Molina, Charlotte Cordonnier, Urs Fischer, Peter Kelly, Vijay K Sharma and 8 more

Open access · goldAbstract readReview
In one paragraph

Review in Therapeutic advances in neurological disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 6 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 6 syntheses or guidelines pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Neuropathologic findings of patients with COVID-19: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Pooled it
  6. Pooled it
  7. Article
  8. Changes in cerebral glucose metabolism among mild long COVID patients: an [18F]FDG PET/CT study.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Article
  16. Neurological Involvements in COVID-19: A hospital-based study.Iranian journal of child neurology · 2023
    Article
  17. Review
  18. Review
  19. Article
  20. Observational

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 10 countries.

Georgios TsivgoulisSecond Department of Neurology, National & Kapodistrian University of Athens, School of Medicine, Rimini 1, Chaidari, Athens 12462, Greece.ORCID https://orcid.org/0000-0002-0640-3797
Lina PalaiodimouSecond Department of Neurology, National and Kapodistrian University of Athens, School of Medicine, "Attikon" University Hospital, Athens, Greece.ORCID https://orcid.org/0000-0001-7757-609X
Aristeidis H KatsanosSecond Department of Neurology, National and Kapodistrian University of Athens, School of Medicine, "Attikon" University Hospital, Athens, Greece.
Valeria CasoStroke Unit, University of Perugia - Santa Maria della Misericordia Hospital, Perugia, Italy.
Martin KöhrmannDepartment of Neurology, University of Essen, Essen, Germany.
Carlos MolinaDepartment of Neurology, Stroke Unit, Hospital Universitari Vall d'Hebrón, Barcelona, Spain.
Charlotte CordonnierInserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Univ. Lille, Lille, France.
Urs FischerDepartment of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Peter KellyHRB Stroke Clinical Trials Network Ireland and Stroke Service/Department of Neurology, Mater University Hospital/University College, Dublin, Ireland.
Vijay K SharmaDepartment of Medicine, Division of Neurology, National University Hospital, Singapore.
Amanda C ChanDepartment of Medicine, Division of Neurology, National University Hospital, Singapore.
Ramin ZandDepartment of Neurology, Neuroscience Institute, Geisinger Health System, Danville, PA, USA.
Amrou SarrajDepartment of Neurology, The University of Texas at Houston, Houston, TX, USA.
Peter D SchellingerDepartment of Neurology and Neurogeriatry, Johannes Wesling Medical Center Minden, University Clinic RUB, Minden, Germany.
Konstantinos I VoumvourakisSecond Department of Neurology, National and Kapodistrian University of Athens, School of Medicine, "Attikon" University Hospital, Athens, Greece.
Nikolaos GrigoriadisSecond Department of Neurology, "AHEPA" University Hospital, Aristotelion University of Thessaloniki, Thessaloniki, Macedonia, Greece.
Andrei V AlexandrovDepartment of Neurology, The University of Tennessee Health Science Center, Memphis, TN, USA.ORCID https://orcid.org/0000-0001-8871-1023
Sotirios Tsiodras4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
National and Kapodistrian University of Athens · GRNational University Hospital · SGUniversity of Tennessee Health Science Center · USAHEPA University Hospital · GRGeisinger Health System · USInserm · FRJohannes Wesling Klinikum Minden · DEUniversity College Dublin · IEUniversity of Bern · CHUniversity of Duisburg-Essen · DEUniversity of Perugia · ITVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide, with a vast majority of confirmed cases presenting with respiratory symptoms. Potential neurological manifestations and their pathophysiological mechanisms have not been thoroughly established. In this narrative review, we sought to present the neurological manifestations associated with coronavirus disease 2019 (COVID-19). Case reports, case series, editorials, reviews, case-control and cohort studies were evaluated, and relevant information was abstracted. Various reports of neurological manifestations of previous coronavirus epidemics provide a roadmap regarding potential neurological complications of COVID-19, due to many shared characteristics between these viruses and SARS-CoV-2. Studies from the current pandemic are accumulating and report COVID-19 patients presenting with dizziness, headache, myalgias, hypogeusia and hyposmia, but also with more serious manifestations including polyneuropathy, myositis, cerebrovascular diseases, encephalitis and encephalopathy. However, discrimination between causal relationship and incidental comorbidity is often difficult. Severe COVID-19 shares common risk factors with cerebrovascular diseases, and it is currently unclear whether the infection

Indexed as

cerebrovascular diseasesCOVID-19healthcare impactneurological manifestationsSARS-CoV-2

Identifiers

PMID32565914
PMCPMC7284455
OpenAlexW3034546965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.